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A B S T R A C T
Vitamin D binding protein (DBP) concentration is known to inﬂuence the availability and bioactivity of vitamin
D metabolites but its diurnal rhythm (DR), its inter-relationships with the DRs of vitamin D metabolites and its
inﬂuence on free vitamin D metabolite concentrations are not well described.
The DRs of plasma total 25(OH)D, total 1,25(OH)2D, DBP, albumin and calculated free 25(OH)D and free
1,25(OH)2D were measured in men and women aged 60–75 years and resident in the UK (n 30), Gambia (n 31)
and China (n 30) with diﬀerences in lifestyle, dietary intake and vitamin D status. Blood samples were collected
every 4 h for 24 h and DRs statistically analysed with Fourier regression.
Gambians had signiﬁcantly higher plasma concentrations of vitamin D metabolites and lower albumin con-
centration compared to the British and Chinese. Signiﬁcant DRs were observed for all analytes and calculated
free vitamin D metabolites (P < 0.01). The pattern of DRs was similar between countries. The magnitude of the
DRs of free 1,25(OH)2D was attenuated compared to that of total 1,25(OH)2D whereas it was not diﬀerent
between total and free 25(OH)D. Relationships between the DRs were generally weak. There was no phase shift
between 1,25(OH)2D and DBP with the strongest cross correlation at 0 h time lag (r= 0.15, P = < 0.001). In
comparison, 25(OH)D correlated less well with DBP (1 h time lag, r= 0.07, P = 0.12).
These data demonstrate a relationship between the DRs of 1,25(OH)2D and DBP, possibly to maintain free
1,25(OH)2D concentrations. In contrast, the DRs of total and free 25(OH)D appeared to be less inﬂuenced by
DBP, suggesting that DBP has comparatively less eﬀect on 25(OH)D concentration and 25(OH)D availability.
This work highlights the importance of standardisation in timing of sample collection particularly for the as-
sessment of plasma protein concentrations.
1. Introduction
Vitamin D is important in calcium, phosphate and bone metabolism
and may be important in other aspects of human health. The total
plasma concentration of the pro-hormone 25-hydroxyvitamin D
(25(OH)D) is measured to determine vitamin D status. The majority of
25(OH)D in the circulation is bound to vitamin D binding protein (DBP)
or albumin with only around 1% circulating in its free form. On the
basis of the free hormone hypothesis it is this free fraction that has
access to the majority of tissues, thus the concentration of free 25(OH)D
may provide a marker of 25(OH)D availability to cells and tissues [1,2].
Some tissues, including the kidney, internalise DBP-bound 25(OH)D via
the plasma membrane transporter protein, megalin. The relative im-
portance of bound and free 25(OH)D for diﬀerent organ systems re-
mains an area of active research. A stronger association between serum
calcium, PTH, bone and vascular outcomes and inﬂammation with free
25(OH)D concentration are reported by some but not all studies (re-
viewed in [3,4]). However, many of these studies were confounded by
the use of particular assays [5]. In addition, 1,25(OH)2D, rather than
25(OH)D, is the biologically active vitamin D molecule that activates
http://dx.doi.org/10.1016/j.jsbmb.2017.07.015
Received 15 March 2017; Received in revised form 2 June 2017; Accepted 15 July 2017
⁎ Corresponding author at: MRC Elsie Widdowson Laboratory, Fulbourn Road, Cambridge CB1 9NL, United Kingdom.
1 Current address: Behavioural Ecology, Department of Zoology, University of Cambridge, Downing Street, Cambridge CB2 3EJ, United Kingdom.
2 Current address: Department of Medicine, University of East Anglia, Norwich NR4 7TJ, United Kingdom.
E-mail addresses: kerry.jones@mrc-ewl.cam.ac.uk, kerry.jones@mrc-hnr.cam.ac.uk (K.S. Jones).
Abbreviations: DBP, vitamin D binding protein; DR, diurnal rhythm; CCV%, coeﬃcient of cyclic variation%
Journal of Steroid Biochemistry and Molecular Biology 172 (2017) 130–135
Available online 19 July 2017
0960-0760/ © 2017 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY license (http://creativecommons.org/licenses/BY/4.0/).
MARK
the vitamin D receptor (VDR) in cells. Like 25(OH)D, the majority of
1,25(OH)2D in the circulation is bound to DBP and some tissues in-
ternalise DBP-bound 1,25(OH)2D. Thus free 1,25(OH)2D concentration
may provide better information on the systemic biological activity of
1,25(OH)2D than its total plasma concentration [6,7].
There is pronounced 24 h variation or diurnal rhythm (DR) in the
plasma concentrations of calcium and phosphate regulating hormones,
in particular PTH which is the main regulator of systemic renal
1,25(OH)2D production [8,9]. Reports of a DR in the plasma con-
centration of 1,25(OH)2D and other vitamin D metabolites are less
consistent. This may be partly due to the potential inﬂuence of a si-
multaneous DR of DBP. The DRs of vitamin D metabolites and DBP and
their inter-relationships may impact on the concentration and propor-
tion of free or bound vitamin D metabolites available to tissues for in-
ternalisation. The inﬂuence of this variation will depend on the extent
to which cells or tissues rely on the megalin-mediated or mega-
lin–independent mechanisms for vitamin D uptake and availability to
activate the VDR. Data on the DRs of 25(OH)D, 1,25(OH)2D and DBP
are required to determine variations in the free fractions to understand
vitamin D metabolism, particularly availability for extra-renal meta-
bolism, and the potential importance of the timing of sample collections
in research studies of clinical populations.
Here, combining novel data on 25(OH)D and DBP with data from a
previous study of 1,25(OH)2D [9], we describe the DRs of plasma
25(OH)D, 1,25(OH)2D, DBP, albumin and free vitamin D metabolites.
The data were derived from studies in three diﬀerent ethnic groups that
allowed exploration of the consistency of DRs in groups despite genetic
and environmental diﬀerences that inﬂuence DBP subtype [10] and
vitamin D status.
2. Methods
Descriptions of participants, study design and statistical analyses
have been published previously in full [9] and are described in sum-
mary below.
2.1. Study location
The studies were conducted at three research centres: (1) MRC
Human Nutrition Research, Cambridge UK, (2) MRC Keneba, The
Gambia and (3) Shenyang Medical College, Shenyang, PR China. The
characteristics of each population were described previously [9,11,12].
The British and Chinese studies were performed in winter when there is
no cutaneous synthesis of vitamin D. The Gambia has two seasons, a
‘wet’ or ‘rainy’ season between June and October characterised by cloud
and heavy rain and a ‘dry’ season characterised by largely clear skies
and little, if any rainfall. This study was performed in the dry season
during which there is expected to be little variation in UVB supply or
potential UVB exposure. The study in each country was approved by
their respective Ethics committee [9] and all participants provided
written, informed consent. All research was performed in accordance
with the Declaration of Helsinki.
2.2. Study participants
Participants were apparently healthy, free-living men and women
aged 60 to 75 years recruited from the local community. Exclusion
criteria were any known pathological disorder that may alter calcium or
bone metabolism [11], haemoglobin < 10 g/dL and plasma creati-
nine > 115 μmol/L [9].
2.3. Study design
This was a secondary analysis of samples and data collected in a
study designed to investigate diﬀerences in the DRs of PTH and bone
metabolism markers [9]. The sample size of 15 individuals per sex from
the original study was based on the ability to detect a 6% diﬀerence
between the peak and nadir of PTH concentration (signiﬁcance level of
5% and power of 80%) [9]. Participants were studied over a 24 h period
and encouraged, as far as possible, to maintain normal activities and
eating and sleeping routines. Sample collections were performed at
standardized times at the participants’ homes and/or respective re-
search centres as per the arrangements for each country [9]. Fasting
blood samples were collected from all participants in the early morning.
Subsequent blood samples were collected in the non-fasting state every
4 h. Participants were assigned to one of two groups whose blood col-
lections were staggered by two hours and the data combined to derive a
group level DR (see Section 2.5 Data analysis) [9].
2.4. Biochemical analysis
Plasma samples for biochemical analysis were transported from The
Gambia and China on dry ice and, as with the UK samples, were stored
at −80 °C until analysis. Plasma total 25(OH)D was measured by
Liaison (Diasorin Ltd, Dartford, UK), total 1,25(OH)2D by radio-
immunoassay (IDS Ltd, Tyne and Wear, UK), as described previously
[9] and DBP by polyclonal antibody ELISA (Immunodiagnostik AG
(Oxford Biosystems, Oxford, UK)) and albumin with an automated
colorimetric method (Kone Lab 20i clinical chemistry, Thermo Scien-
tiﬁc, Vantaa, Finland). All samples were measured in duplicate and
analysis repeated if the CV was more than 10%. Assay performance was
measured using kit and in-house controls and performance was in ac-
ceptable limits. External quality assurance was obtained through
DEQAS (www.deqas.org) for plasma 1,25(OH)2D and 25(OH)D and
traceable to NIST standards for 25(OH)D. This Diasorin Liaison assay in
our lab has been calibrated against standardized LC–MS/MS reference
measurement procedures developed by NIST and Ghent University. The
relationship between the two methods is described by the equation:
Diasorin Liaison = 1.023*LC–MS/MS–2.52 nmol/l (r2 = 0.8751,
n = 186).
2.5. Data analysis
Data are presented as the mean (SD) or geometric mean (95% CI).
For consistency with DR model parameters which are logged for ana-
lysis, baseline 25(OH)D, 1,25(OH)2D, DBP and albumin are presented
as geometric means. Free concentrations of 25(OH)D and 1,25(OH)2D
were calculated using published mathematical models [13] that include
concentrations of total 25(OH)D, total 1,25(OH)2D, DBP and albumin.
Group diﬀerences in baseline characteristics and early-morning fasted
blood samples were tested by ANOVA with Scheﬀé post-hoc test or χ2
test. We made no adjustment for multiple testing.
Fourier regression was used to model diurnal variation as previously
described [9,14]. All concentration data were logged before analysis
and data were modelled by country. The Fourier model uses two pairs
of sine and cosine terms as independent predictors of the rhythm and a
random eﬀect to allow for individual intercepts and within-individual
correlation of data from the multiple data points per individual. The
signiﬁcance of the rhythm was determined by testing the null hypoth-
esis that all Fourier coeﬃcients were zero. Diﬀerent methods are
available to measure and compare the amplitudes of cyclic rhythms
[15]. We used a method that allows the assessment and comparison of
the magnitude of the amplitude on a common scale. It was expressed as
a mean (95% CI) coeﬃcient of cyclic variation (CCV%), calculated as
the square root of half the sum of the squared coeﬃcients of the Fourier
terms [15]. Diﬀerences in CCV% were compared between countries and
between bound and free metabolites using the z-test. Country diﬀer-
ences in 24 h means were tested by including country in a regression
model of the plasma concentration of the analyte of interest against the
sine and cosine parameters. Cross-correlation analysis on a per country
basis was used to examine the relationship between variables and the
strongest correlation, r, and lag time are presented. Statistical analysis
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and modelling was performed in Stata 13 SE (Stata Corp, TX, USA) and
z-tests in Microsoft Excel.
3. Results
Participant characteristics and measured fasting, baseline bio-
chemistry are shown in Table 1.
Gambians had signiﬁcantly higher total 25(OH)D and total
1,25(OH)2D plasma concentrations and signiﬁcantly lower albumin
concentrations compared to the British and Chinese. DBP was slightly
lower in Gambians but was only signiﬁcant when compared with the
British (Gambia vs China, P = 0.16). Albumin concentration was
lowest in the Gambians and highest in the Chinese and diﬀerences were
signiﬁcant between all countries. Free 25(OH)D and free 1,25(OH)2D
were higher in the Gambians compared to the other groups and there
were no diﬀerences between the British and Chinese.
Results of the Fourier regression are shown in Fig. 1 and Table 2.
The 24 h mean concentrations derived from the DR analysis were
generally similar to the fasting, baseline concentrations (within 0–15%)
with vitamin D metabolite concentrations consistently higher in Gam-
bians compared to the British and Chinese (Table 2 and Fig. 1). In
contrast to the fasting values, 24 h mean concentrations of total 25(OH)
D, DBP and albumin were higher in the British compared to the Chinese
(Tables 1 and 2).
A signiﬁcant DR was present for all analytes in each country, with
the exception of free 25(OH)D in the Chinese. Total 25(OH)D, total
1,25(OH)2D, DBP and albumin had lower values during the night and
higher values during the day in all groups. The DR of free 1,25(OH)2D
was attenuated compared to that of total 1,25(OH)2D as evidenced by
the signiﬁcantly lower CCV% (all P < 0.01). In contrast, the CCV%s
between total 25(OH)D and free 25(OH)D were not diﬀerent for any
country (P > 0.05). There were no country diﬀerences in the magni-
tude of the rhythm (assessed by CCV%) for DBP, albumin or free
25(OH)D and there were no consistent country diﬀerences between the
other metabolites.
In all countries, the strongest and most consistent cross correlation
was between predicted values for DBP and albumin (all countries 0 h
time lag, r 0.94–0.98, P < 0.0001 and DBP and total 1,25(OH)2D (all
countries 0 h time lag, all r 0.95 P < 0.0001). The cross correlation
between total 25(OH)D and DBP was also highly signiﬁcant (r
0.84–0.92; all P < 0.0001) but the lag times were less consistent,
varying between 0 and 3 h, compared to cross correlation between DBP
and total 1,25(OH)2D. We examined the cross correlation between PTH
and total and free 1,25(OH)2D in each country (all P < 0.0001) and
found similar patterns for both total and free 1,25(OH)2D.
4. Discussion
We have shown signiﬁcant diurnal rhythms (DR) in total 25(OH)D,
total 1,25(OH)2D, DBP, albumin and the free concentrations of both
25(OH)D and 1,25(OH)2D. In this study, although the magnitude of the
free 1,25(OH)2D DR was signiﬁcant, it was attenuated compared to
total 1,25(OH)2D as reﬂected by its smaller magnitude (CCV%). This
suggests that total and free 1,25(OH)2D concentrations respond to
variation in DBP concentration and that the free 1,25(OH)2D con-
centration is maintained within a relatively narrow range through
known feed-back mechanisms such as upregulation of CYP24A1, which
catabolizes 1,25(OH)2D. This is in accordance with the strict metabolic
control of the circulating concentration of 1,25(OH)2D and the rapid
feedback mechanism upon its activation of the VDR. There are reports
of a DR of 1,25(OH)2D in some [9,16] but not all human studies
[17–19]. These diﬀerences may be due to the methods of analysis of the
rhythm, sample size or the study population [16]. Only one study has
reported a signiﬁcant DR in the plasma concentrations of DBP, a study
that showed no DRs in the calculated free-1,25(OH)2D index [16]. A
single study has demonstrated a DR of 25(OH)D in humans [20].
Evidence of the potential inﬂuence of the DBP concentration on
plasma of 1,25(OH)2D also comes from other human and animal stu-
dies. A signiﬁcant positive association between plasma DBP and
1,25(OH)2D concentration has been reported in a cohorts in Denmark
[21] and Sweden [4] and in pregnancy an increase in DBP is associated
with an increase in 1,25(OH)2D [22]. In DBP-null mice, circulating total
1,25(OH)2D was only 1% of that in the wild-type but cellular uptake
and biological activity were not compromised [23] potentially because
free 1,25(OH)2D is regulated and thus was maintained within narrow
ranges.
In contrast, there was no diﬀerence in the CCV% between total
25(OH)D and free 25(OH)D and the DR pattern of both total and free
25(OH)D poorly reﬂected that of the DRs of DBP and albumin. This
indicates that free and total 25(OH)D do not respond as strongly as
those of 1,25(OH)2D to changes in the plasma concentrations of its
binding proteins, possibly because the concentration of free 25(OH)D is
more dependent on 25(OH)D concentration than DBP concentration
[24]. This is also consistent with the long plasma half-life of 25(OH)D
(2–3 weeks) [25] and the limited metabolic control of the plasma
concentration compared to 1,25(OH)2D that has a much shorter plasma
half-life (∼3 d) [26]. This observation may be surprising given that, of
all the vitamin D metabolites, 25(OH)D has the highest aﬃnity for DBP.
The relationship between vitamin D metabolites and DBP and their
free fractions may inﬂuence vitamin D availability, their half-lives and
biological activity. Vitamin D metabolites are thought to be transported
into cells predominantly by two mechanisms (1) DBP interaction and
internalisation with the plasma membrane transporter protein,
megalin, and (2) diﬀusion of the free metabolite across the cell mem-
brane. In the kidney the megalin route is thought to be predominant but
uptake of 25(OH)D into other cell types (e.g. monocytes [27]) is
thought to be dependent on the diﬀusion of the free fraction. These and
many other cell types express CYP27B1 and can produce 1,25(OH)2D
Table 1
Baseline participant characteristics and fasting, early-morning biochemistry.
Britain (n 30) Gambia (n 31) China (n 30)
Age, y 65.5 (3.9) 66.1 (4.3) 64.4 (3.5)
Weight, kg 79.1 (73.3, 85.4)G**,C** 56.1 (53.1, 59.2)B**,C* 62.9 (60.1, 65.9)B**,C*
Height, m 1.72 (0.11)G**,C* 1.62 (0.10)B** 1.64 (0.08)B*
BMI, kg/m2 26.9 (25.0, 28.9)G**,C* 21.4 (10.5, 22.4)B** 23.0 (22.1, 24.0)B*
Sex, female/male 14/16 17/14 14/16
25(OH)D, nmol/L 37 (30,44)G** 59 (52, 65)B**,C** 32 (27, 38)G**
1,25(OH)2D, pmol/L 124 (110, 140)G** 186 (172, 201)B**,C** 123 (110, 137)G**
DBP, μmol/L 8.0 (7.5, 8.5)[n29],G* 7.2 (6.9, 7.6)B* 7.8 (7.4, 8.2)
Albumin, μmol/L 571 (557, 585)G**,C** 495 (481, 510)B**,C** 660 (646, 674)G**,C**
Free 25(OH), pmol/L 11.1 (9.1, 13.4) [n29],G** 19.5 (17.5, 21.8)B**,C** 9.7 (8.2, 11.4)G**
Free 1,25(OH)2D, pmol/L 0.85 (0.76, 0.95)[n29],G** 1.42 (1.31, 1.54)B**,C** 0.83 (0.74, 0.93)G**
Values are mean (SD) or geometric mean (95%). Group diﬀerences were tested by one-way ANOVA with Scheﬀé post-hoc tests or Chi-squared test. Free 25(OH)D and free 1,25(OH)2D are
calculated values. Superscripts indicate diﬀerences between countries (B-Britain; G-Gambia; C-China); * P < 0.05, ** P < 0.001
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for intra- or paracrine eﬀects. Our understanding of the relative im-
portance of these two mechanisms and their regulation in other tissue
and cell types is in its infancy.
The absence of a pronounced DR of free 1,25(OH)2D is of interest in
the context of the rhythmicity of PTH and earlier reported signiﬁcant
cross correlations between PTH and total 1,25(OH)2D [9]. These data
may imply that PTH regulates the production of total 1,25(OH)2D but
may not inﬂuence its free fraction. The latter may be predominantly
controlled by feedback mechanisms upon VDR activation and/or the
rate of 1,25(OH)2D internalisation and catabolism. There may be dif-
ferences in the DRs of PTH and bone turnover markers in people with
pathological conditions such as osteoporosis [28,29] and diabetes [20]
but this has so far not been shown for 1,25(OH)2D. Plasma concentra-
tions of 1,25(OH)2D reﬂect the renal rather than the extra-renal pro-
duction of 1,25(OH)2D. Other cell types which express the CYP27B1
and CYP24A1 may produce and catabolize 1,25(OH)2D intracellularly
and thus may have an independent DR. Further investigation is needed
to understand whether systemic or intracellular rhythmicity are in-
volved in the regulation of the circadian rhythm of bone remodelling
and other cell types, such as adipose-derived stem cells [30,31].
DBP and albumin exhibited signiﬁcant DRs similar to those reported
in previous studies [16,32,33] and their patterns were similar for all
three groups. Since these two molecules have very diﬀerent half-lives
(DBP∼ 2-3 d [34]; albumin∼ 20 d [35]) it is surprising that the DRs
are similar and suggests that the DR in these plasma proteins may be
related less to metabolism and more to other factors aﬀecting their
concentration. For example, circadian rhythms in glomerular ﬁltration
rate may aﬀect and inﬂuence the daily rhythm of higher molecular
weight proteins such as albumin and DBP [33]. Also hydration status,
posture and nocturnal haemodilution (whereby blood volume is greater
at night than in the daytime [16]) may alter the volume of distribution,
or transfer and the distribution between interstitial and intravascular
ﬂuid compartments. Such a change in dilution volume and tissue dis-
tribution could produce variability in plasma DBP and albumin con-
centration leading to variability in total 1,25(OH)2D concentration and
maintenance of free 1,25(OH)2D.
Fasting baseline and 24 h mean concentrations of total 25(OH)D
and total 1,25(OH)2D were higher in Gambian compared to British and
Chinese participants. Elevated 1,25(OH)2D in Gambians is well docu-
mented and is probably related to their low dietary calcium intake and
high PTH concentration as well as potentially the supply of 25(OH)D
[9,11,36]. Lower plasma albumin in black populations has been ob-
served previously in some studies in the US [37] and in previous
comparative studies in The Gambia [38]. The lower albumin con-
centrations in Gambians may be due to genetic factors, higher levels of
inﬂammation or lower dietary protein intake. Slightly higher plasma
albumin was reported in Asians in the US [39] but the reasons for the
higher albumin in our Chinese group are unclear. Whist albumin cir-
culates at much higher concentrations than DBP it’s contribution as a
carrier of vitamin D metabolites is relatively minor due to a much lower
binding aﬃnity. Consequently, variation in calculated free 25(OH)D or
1,25(OH)2D concentration attributable to albumin is much lower than
that of 25(OH)D, 1,25(OH)2D or DBP concentration. For DBP con-
centrations, large diﬀerences between populations were inﬂuenced by
the assay used for quantiﬁcation [40] and data generated using other
assays and mass spectrometric-based methods suggest less variation in
DBP concentration due to race or genotype [5]. The timing of the peak
and nadir of the DRs of DBP were similar between groups despite dif-
ferences in lifestyle, diet and vitamin D status [9]. This suggests that
these DRs are inﬂuenced by factors in common between countries, in-
cluding those discussed above, and potentially an endogenous circadian
component. Known environmental and genetic diﬀerences between
Fig. 1. Vitamin D metabolites and their binding proteins exhibit signiﬁcant diurnal rhythms that are attenuated for calculated free 1,25(OH)2D. Diurnal rhythms were assessed in British
(orange circles), Gambian (blue diamonds) and Chinese (green triangles) older people. Lines represent the ﬁtted values following Fourier regression and the error bars 2 * the upper and
lower standard error. (For interpretation of the references to colour in this ﬁgure legend, the reader is referred to the web version of this article.)
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groups did not appear to have an inﬂuence on the observation that the
DR magnitudes were diﬀerent between free 1,25(OH)2D and total
1,25(OH)2D.
This exploratory study has some limitations. DRs were calculated
based on a limited number of data points and although, as much as
practicable, participants were asked to follow their normal routines, by
the nature of these types of studies this was not entirely possible [9]. By
their nature, invasive studies of this type are relatively small and this
study was no exception. The study results for each group may therefore
not be fully representative of their respective populations. The use of
calculated free 25(OH)D and 1,25(OH)2D for assessing free concentra-
tions of vitamin D metabolites may only be suitable for use in healthy
populations. Where vitamin D metabolite or DBP concentrations are
signiﬁcantly altered due to physiological or pathophysiological condi-
tions they may be less applicable [6,25,41]. We used a calculation that
includes concentrations of 25(OH)D, 1,25(OH)2D, DBP and albumin but
did not consider DBP genotype. DBP genotype, by aﬀecting binding
aﬃnity for 25(OH)D, is suggested to aﬀect the free 25(OH)D con-
centration [13]. However, other studies have shown that there are no
diﬀerences in the aﬃnity of 25(OH)D for DBP (summarised in [24]).
Adjustment for DBP genotype would likely make only minor diﬀerences
to the calculated free metabolite concentrations [13] and no diﬀerence
to patterns within an individual.
In conclusion, we have shown signiﬁcant DRs in vitamin D
metabolite and DBP concentrations. These data show the importance of
standardisation of the timing of sample collection in studies. The sig-
niﬁcant correlation between 1,25(OH)2D and DBP and lower CCV% for
free 1,25(OH)2D compared to total 1,25(OH)2D suggests that
1,25(OH)2D may respond to changes in DBP possibly to maintain free
1,25(OH)2D concentrations. In contrast, the DRs of total and free
25(OH)D appeared to be less inﬂuenced by DBP, suggesting that DBP
has comparatively less eﬀect on 25(OH)D concentration.
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